Howard Hughes Medical Institute’s Chemours CC Stock Holding History

Howard Hughes Medical Institute’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-29,993	Closed	-$1.14M	–	47
2017 Q2	$1.14M	Sell	29,993 -34,560	-54%	-$1.36M	0.21%	67
2017 Q1	$2.48M	Sell	64,553 -46,111	-42%	-$1.39M	0.46%	48
2016 Q4	$2.44M	Buy	110,664 +10,690	+11%	+$219K	0.56%	45
2016 Q3	$1.6M	Buy	99,974 +46,489	+87%	+$531K	0.41%	55
2016 Q2	$441K	Buy	53,485 +32,590	+156%	+$290K	0.15%	93
2016 Q1	$146K	Buy	+20,895	New	+$105K	0.03%	122

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Howard Hughes Medical Institute's CC Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Chemours (CC) in Q3 2017, closing a stake of 29,993 shares — an estimated $1.14M sold.

Howard Hughes Medical Institute first reported a position in CC in Q1 2016 and held it in 6 quarters. The position peaked at $2.48M in Q1 2017. 500 funds tracked by Wall St. Rank hold CC as of Q3 2017.

Howard Hughes Medical Institute reported no remaining Chemours position as of Q3 2017 after selling out during the quarter.
Howard Hughes Medical Institute sold 29,993 Chemours shares in Q3 2017, an estimated $1.14M.
Howard Hughes Medical Institute first reported a position in Chemours in Q1 2016 and held it in 6 quarters.
Howard Hughes Medical Institute's Chemours position peaked at $2.48M in Q1 2017.
500 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.